We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Gamma Interferon Also Fights Fungal Infections

By HospiMedica staff writers
Posted on 13 Nov 2007
Interferon, a known cure for viral infections, may also be a strong weapon in the battle against fungal infections in immuno-compromised patients, according to a new study.

Researchers at Stanford University (CA, USA) found that when gamma interferon was given to mice infected with Cryptococcus along with amphotericin B--a standard antifungal treatment--the rate of cure was significantly higher than using one therapy alone. More...
Further tests on other fungal infections, including blastomycosis, candidosis, and aspergillosis showed that gamma interferon, when used as an adjunctive therapy, has beneficial effects in terms of the reduction of the fungus in the organs and on animal survival. The researchers found that Gamma interferon works by enhancing the mechanisms of neutrophils, converting them into more potent killers of fungi. The researchers also explored the possibility of using gene therapy for delivering gamma interferon into the nervous system to combat fungal meningitis. The study was published in the November 2007 issue of Microbiology Today.

"Studies of this type suggest a potential clinical use for specific gamma interferon gene therapy in the future,” said co-author Dr. David Stevens of the division of infectious diseases and geographic medicine. "Treatment with gamma-interferon offers a new additional approach to treatment and it provides a new approach to treating difficult diseases. However, clinical trials must document the benefit for patients.”

Interferons (IFNs) are natural proteins that belong to the large class of glycoproteins known as cytokines that are produced by the cells of the immune system in response to challenges by foreign agents such as viruses, bacteria, parasites, and tumor cells. Interferons assist the immune response by suppressing virus reproduction, stimulating other T cells, and activating macrophage cells.


Related Links:
Stanford University

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Imaging Table
Stille imagiQ2
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.